Related Experiment Video

Updated: Jun 22, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

[Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance]

Jia-nian Chen1, Qi Shen, Shao-shun Li

  • 1School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|June 24, 2009
PubMed

Insights

Nanoparticle-based drug delivery systems show promise in overcoming multi-drug resistance (MDR) in cancer chemotherapy. These systems enhance drug concentration in tumors, reduce side effects, and improve overall cancer therapy outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Context:

  • Multi-drug resistance (MDR) in cancer cells is a significant challenge in chemotherapy, leading to treatment failure.
  • The precise mechanisms underlying MDR are not fully understood, complicating therapeutic strategies.
  • Existing chemotherapy often struggles to effectively target tumor cells while sparing healthy tissues.

Purpose:

  • This review aims to summarize recent advancements in nanoparticle-based drug delivery systems designed to overcome MDR.
  • To explore the mechanisms by which nanoparticles can reverse or mitigate MDR.
  • To highlight the potential of nanotechnology in enhancing cancer treatment efficacy.

Summary:

  • Nanoparticle drug delivery systems, including non-modified, ligand-modified, and multifunctional types, are reviewed for their ability to combat MDR.
  • These systems work by counteracting drug efflux pumps, thereby increasing intracellular drug concentrations within tumor cells.
  • The combination of nanotechnology with active and passive targeting strategies offers a promising approach to cancer therapy.

Impact:

  • Nanoparticle-based delivery can significantly improve the efficacy of anti-cancer drugs by overcoming resistance mechanisms.
  • These systems have the potential to reduce systemic toxicity by concentrating therapeutic agents at the tumor site.
  • The integration of nanotechnology in drug delivery represents a significant advancement with broad prospects for improving cancer treatment outcomes.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...